RecruitingNot ApplicableNCT07335354
A Study of a Decision Tool for People Considering Breast Reconstruction Surgery
Breast Reconstruction Decision Aid (RECONJOINT)
Sponsor
Memorial Sloan Kettering Cancer Center
Enrollment
131 participants
Start Date
Jan 5, 2026
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to find out whether it is practical (feasible) to do a larger study looking at the effectiveness of the Breast Reconstruction Decision Aid Tool (RECONJOINT) for breast reconstruction surgery.
Eligibility
Min Age: 18 Years
Inclusion Criteria11
- Focus Group Participants
- A diagnosed genetic predisposition to breast cancer or a diagnosis of ductal carcinoma in situ or any invasive cancer confirmed through review of the medical record
- ≥18 years old
- Considering post-mastectomy breast reconstruction
- RCT Participants (Patients)
- A diagnosed genetic predisposition to breast cancer or a diagnosis of ductal carcinoma in situ or any invasive cancer confirmed through review of the medical record
- ≥18 years old
- Considering post-mastectomy breast reconstruction
- Have an appointment scheduled for consultation with a plastic surgery provider
- RCT Participants (Physicians)
- Provides breast reconstruction care ≥ 50% of the time. This is defined as over half of the surgeon's cases in the preceding calendar year being related to breast reconstruction surgery.
Exclusion Criteria11
- Focus Group Participants
- Not considering post-mastectomy breast reconstruction
- Non-English proficiency
- RCT Participants (Patients)
- Not considering postmastectomy breast reconstruction
- Recurrent or metastatic breast cancer
- Male sex
- Non-English proficiency
- RCT Participants (Physicians)
- Does not provide breast reconstruction care at least 50% of the time
- Non-English proficiency
Interventions
OTHERRECONJOINT
RECONJOINT is a Breast Reconstruction Decision Aid
Locations(8)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07335354
Related Trials
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
NCT0661828763 locations
Early Phase Study of KESONOTIDE™in Participants With Solid Tumours
NCT069260753 locations
Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System
NCT052915071 location
Cardiac Outcomes With Near-Complete Estrogen Deprivation
NCT053096553 locations
Non-interventional Study to Assess the Effectiveness and Safety of Ribociclib in the Adjuvant Therapy of Hormone Receptor Positive (HR+) HER2-negative Stage II and III Breast Cancer in Real Clinical Practice in Russia
NCT0693085934 locations